← Leaderboards
Sarah Ann Flowers
Georgetown University
$4,203,957
Attributed
$5,692,436
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,692,436 · 3
By mechanism
R01$4,914,936 · 2
R56$777,500 · 1
Top collaborators
- Gary E Gibson2 shared
- Sheng Zhang2 shared
Most similar at Georgetown University
Same institution · by research overlap
- Rachel Lauren Nosheny$8,318,133
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposModificationLocationS DiseaseGenetic Risk FactorBrainResponsePlasmaSugarGenotypePharmaceutical PreparationsApolipoprotein EAstrocytesAffectInduced Pluripotent Stem CellEnzymesHepatocyteLate Onset Alzheimer DiseaseCoculture TechniquesGlycoproteomicsAbeta AccumulationGlycoproteinsBindingGlycosylation
Grant awards (9)
Mechanistic links between the benefits of pharmacologically high thiamine (vitamin B1) in Alzheimer's disease to Advanced Glycation Endproducts (AGE)$1,213,766
R01 · FY2025 · AG
Apolipoprotein E glycosylation and its role in Alzheimer's disease pathogenesis$538,880
R01 · FY2025 · AG · contact PI
Mechanistic links between the benefits of pharmacologically high thiamine (vitamin B1) in Alzheimer's disease to Advanced Glycation Endproducts (AGE)$1,018,953
R01 · FY2024 · AG
Apolipoprotein E glycosylation and its role in Alzheimer's disease pathogenesis$549,878
R01 · FY2024 · AG · contact PI
Apolipoprotein E glycosylation and its role in Alzheimer's disease pathogenesis$531,153
R01 · FY2023 · AG · contact PI
Apolipoprotein E glycosylation and its role in Alzheimer's disease pathogenesis$531,153
R01 · FY2022 · AG · contact PI
Apolipoprotein E glycosylation and its role in Alzheimer's disease pathogenesis$531,153
R01 · FY2021 · AG · contact PI
Apolipoprotein E glycosylation and its role in Alzheimer's disease pathogenesis$388,750
R56 · FY2019 · AG · contact PI
Apolipoprotein E glycosylation and its role in Alzheimer's disease pathogenesis$388,750
R56 · FY2018 · AG · contact PI